Gregoire H&N

42
Conformal radiotherapy and IMRT Conformal radiotherapy and IMRT in Head and Neck Tumors in Head and Neck Tumors The “academic” view point The “academic” view point

Transcript of Gregoire H&N

Page 1: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

The “academic” view point

The “academic” view point

Page 2: Gregoire H&N

ICRU report 62, 1999

• Gross Tumor Volume: GTV

• Clinical Target Volume: CTV

• Planning Target Volume: PTV

Target volumes in Radiation Target volumes in Radiation OncologyOncology::ICRU ICRU definitiondefinition

Page 3: Gregoire H&N

ll 15 head & neck tumors15 head & neck tumorsll 15 brain tumors15 brain tumorsll 3 different masks (3, 4 & 5 FP) 3 different masks (3, 4 & 5 FP) ll 3 fictitious 3 fictitious isocentersisocenters

Immobilization of Immobilization of Head & Neck patientsHead & Neck patients

Page 4: Gregoire H&N

ll 915 portals images acquired.915 portals images acquired.ll 98 %98 % analysedanalysed..

ll Total Displacement.Total Displacement.uu SIM SIM -- EPIDEPIDii

ll Systematic Displacement.Systematic Displacement.uu M(SIM M(SIM -- EPIDEPIDii))

ll Random Displacement.Random Displacement.uu (SIM (SIM -- EPIDEPIDii) ) -- [ M(SIM [ M(SIM --

EPIDEPIDii)])]

ll IntraobserverIntraobserver variation:variation:0.7 mm (10.7 mm (1 SdSd).).

Immobilization of Head & Neck patientsImmobilization of Head & Neck patients

Page 5: Gregoire H&N

0.00.10.20.30.40.50.60.70.80.91.0

0 1 2 3 4 5 6 7 8 9 10Deviation from the isocenter (mm)

Cum

ulat

ive

inci

denc

eHead

(3-5 FP) Total 3Total 3--DDdeviationsdeviations

0.00.10.20.30.40.50.60.70.80.91.0

0 1 2 3 4 5 6 7 8 9 10Deviation from the isocenter (mm)

Cum

ulat

ive

inci

denc

e

Neck(3-5 FP)

00.10.20.30.40.50.60.70.80.9

1

0 1 2 3 4 5 6 7 8 9 10 11 12 13 14Deviation of the isocenter (mm)

Cum

ulat

ive

inci

denc

e Shoulder(4 & 5 FP)

Page 6: Gregoire H&N

Characteristics of currentCharacteristics of currentimaging modalitiesimaging modalities

CT MRI PET fMRIImage characteristics

skin contour + ± ± -soft-tissue contrast ± + - -bone contrast + ± - -air contrast + ± ± -metallic artefacts + ± - ±movement artefacts - + ± +

Machine characteristicslarge “tunnel” size + - - -distortion - + ± +electron density + - ± -multiplannar imaging - + ± +

Page 7: Gregoire H&N

Image acquisitionImage acquisition

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

• Dual detector spiral CT

• 2.7 mm collimation, pitch 0.7, reconstruction of 2 - 2.5 mm

• Display matrix of 512 x 512 pixels

• Contrast enhancement (interstitial and blood vessel contrast)

Page 8: Gregoire H&N

Conformal radiotherapy:reference coordinates

Page 9: Gregoire H&N

Conformal radiotherapy:3D reconstruction

Page 10: Gregoire H&N

Conformal radiotherapy:3D reconstruction

Page 11: Gregoire H&N

Conformal radiotherapy:image display

Page 12: Gregoire H&N

Cervical lymph node groups(MSKCC classification)

Adopted by the Academy’s Committee for Head & Neck Surgery and Oncology

Robbins et al, 1991

The The presentpresent … … which which CTV for the neck ?CTV for the neck ?

Page 13: Gregoire H&N

State of the art

• Predictive pattern of lymph node involvement in HNSCC

• Selective neck treatment (irradiation or dissection) for selected N stage

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Definition of the extend of the CTV in the neck

Page 14: Gregoire H&N

IIIV

III

Ia

Ib

II

Ia

Ib

The present …CT-based delineation oflymph node levels in the neck

Grégoire et al., 2000

Ia

Ib

II

RP

VI

VIII

Page 15: Gregoire H&N

Conformal radiotherapy:volume delineation

Page 16: Gregoire H&N

Conformal radiotherapy:volume delineation

Page 17: Gregoire H&N

Conformal radiotherapy:Beam selection

Page 18: Gregoire H&N

BEV

Page 19: Gregoire H&N

Conformal radiotherapy:Dose distribution

Page 20: Gregoire H&N

Conformal radiotherapy:Dose distribution

Page 21: Gregoire H&N

Conformal radiotherapy:Dose volume histogram

Page 22: Gregoire H&N

Conformal radiotherapy:Dose volume histogram

Page 23: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Mr H. D. (77 years): T3-N0-M0 base of tongue (ICD0-10: C01)

Page 24: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Mr H. D. (77 years): T3-N0-M0 base of tongue (ICD0-10: C01)

Target volumesTarget volumes• T: CTV1: GTV + 1.5 cm margin

CTV2: GTV + 0.5 cm marginPTV1&2 : CTV + 4 mm

• N:CTV: R & L LII - IVPTV: CTV + 4 mm

Dose prescriptionDose prescription• T: PTV1: 50 Gy, 25x2 Gy

PTV2: 70 Gy, 35x2 Gy• N:PTV: 50 Gy, 25x 2Gy

Page 25: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Rx 6 MV40 Gy

Rx 6 MV30 Gy

Rx 6 MV50 Gy

Elect 8 MeV10 Gy

“Antique”(7 fields)

Page 26: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Dose (Dose (GyGy) at various organs at risk) at various organs at riskAntique Middle-age Art nouveau

PTV 55 GyDmean 63.2 60.1 59.2Dmax 79,1 76.6 74.6Dmin 10.0 39.1 44.4SD 10.2 9.5 8.1

PTV 70 GyDmean 72.4 71.7 70.6Dmax 76.9 76.5 74.6Dmin 67.4 65.2 67.0SD 1.8 2.1 1.5

L parotidDmedian 68.7 52.1 50.7Dmax 72.8 72.5 71.8Dmin 46.4 8.4 5.4SD 7.6 12.2 15.5

R parotidDmedian 69.6 65.7 40.6Dmax 72.9 72.6 55.9Dmin 62.1 4.4 3.6SD 1.7 24.9 16.7

Page 27: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Dose (Dose (GyGy) at various organs at risk) at various organs at riskAntique Middle-age Art nouveau

Spinal cordDmean 22.8 19.6 22.7Dmax 43.0 41.9 47.6Dmin 5.5 3.3 2,7SD 16.0 16.1 18.0

MandibulaDmedian 71.5 68.9 60.5Dmax 76.8 74.5 72.2Dmin 51.1 4.8 3.7SD 2.2 22.0 17.4

Internal contourDmedian 41.6 13.6 19.3Dmax 79.2 76.6 74.6Dmin 2.0 1.2 1.1SD 21.5 23.4 22.2

Page 28: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

“Middle Age”(9 fields)

Rx 6 MV40 Gy

Rx 6 MV20 Gy

Rx 6 MV50 Gy

Rx 6 MV10 Gy

Elect 8 MeV10 Gy

Page 29: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

“Middle Age”(9 fields)

Rx 6 MV40 Gy

Rx 6 MV20 Gy

Rx 6 MV50 Gy

Rx 6 MV10 Gy

Elect 8 MeV10 Gy

Page 30: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Dose (Dose (GyGy) at various organs at risk) at various organs at riskAntique Middle-age Art nouveau

PTV 55 GyDmean 63.2 60.1 59.2Dmax 79,1 76.6 74.6Dmin 10.0 39.1 44.4SD 10.2 9.5 8.1

PTV 70 GyDmean 72.4 71.7 70.6Dmax 76.9 76.5 74.6Dmin 67.4 65.2 67.0SD 1.8 2.1 1.5

L parotidDmedian 68.7 52.1 50.7Dmax 72.8 72.5 71.8Dmin 46.4 8.4 5.4SD 7.6 12.2 15.5

R parotidDmedian 69.6 65.7 40.6Dmax 72.9 72.6 55.9Dmin 62.1 4.4 3.6SD 1.7 24.9 16.7

Page 31: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Dose (Dose (GyGy) at various organs at risk) at various organs at riskAntique Middle-age Art nouveau

Spinal cordDmean 22.8 19.6 22.7Dmax 43.0 41.9 47.6Dmin 5.5 3.3 2,7SD 16.0 16.1 18.0

MandibulaDmedian 71.5 68.9 60.5Dmax 76.8 74.5 72.2Dmin 51.1 4.8 3.7SD 2.2 22.0 17.4

Internal contourDmedian 41.6 13.6 19.3Dmax 79.2 76.6 74.6Dmin 2.0 1.2 1.1SD 21.5 23.4 22.2

Page 32: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Rx 6 MV 50 Gy

“Art nouveau” (10 fields, 12 segments )

Ant.RPO LPO

SRAO SLAO

Post. Seg. 1 Post. Seg. 2

Page 33: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Rx 6 MV 20 Gy

“Art nouveau” (11 fields, 12 segments )

Ant. RAO LPO

LAO1 LAO2

Page 34: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Dose (Dose (GyGy) at various organs at risk) at various organs at riskAntique Middle-age Art nouveau

PTV 55 GyDmean 63.2 60.1 59.2Dmax 79,1 76.6 74.6Dmin 10.0 39.1 44.4SD 10.2 9.5 8.1

PTV 70 GyDmean 72.4 71.7 70.6Dmax 76.9 76.5 74.6Dmin 67.4 65.2 67.0SD 1.8 2.1 1.5

L parotidDmedian 68.7 52.1 50.7Dmax 72.8 72.5 71.8Dmin 46.4 8.4 5.4SD 7.6 12.2 15.5

R parotidDmedian 69.6 65.7 40.6Dmax 72.9 72.6 55.9Dmin 62.1 4.4 3.6SD 1.7 24.9 16.7

Page 35: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Dose (Dose (GyGy) at various organs at risk) at various organs at riskAntique Middle-age Art nouveau

Spinal cordDmean 22.8 19.6 22.7Dmax 43.0 41.9 47.6Dmin 5.5 3.3 2,7SD 16.0 16.1 18.0

MandibulaDmedian 71.5 68.9 60.5Dmax 76.8 74.5 72.2Dmin 51.1 4.8 3.7SD 2.2 22.0 17.4

Internal contourDmedian 41.6 13.6 19.3Dmax 79.2 76.6 74.6Dmin 2.0 1.2 1.1SD 21.5 23.4 22.2

Page 36: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Forward planning IMRT

• « human optimization »

Inverse planning IMRT

• Dose-volume constraints & weights for PTV and OARs

• optimization algorithms

• Penalty function

Page 37: Gregoire H&N

ll Spare cordSpare cordll Spare left parotid Spare left parotid ll 15 segments15 segmentsll 10 levels10 levels

1 6.Cummulative % of MUsSegment #

Courtesy of C. Field

Inverse planning IMRT for Inverse planning IMRT for Head and Neck TumorsHead and Neck Tumors

Page 38: Gregoire H&N

Inverse planning IMRT for Inverse planning IMRT for Head and Neck TumorsHead and Neck Tumors

PTV

Spared parotid gland

Courtesy of C. Field

Page 39: Gregoire H&N

Parotid Parotid gland gland functionfunction

lemonjuice

370 MBq 99mTc-pertechnetate

Page 40: Gregoire H&N

Parotid Parotid gland gland functionfunctionObjective assessment

0

10

20

30

40

50

60

70

80

90

100

0 10 20 30 40 50 60 70

Bilateral irradiationUnilateral irradiation

R= 0,77M

axim

um s

ecre

tion

(%)

Mean parotid dose (Gy)

Page 41: Gregoire H&N

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Duration of treatment planning procedure

2D planning Forward planning Inverse planning(St-Luc) (Edmonton Cancer center)

Volume delineation 0 - 0.25h 2 - 3h 1 - 1.5h

Planning 0.25h 2 - 8h 1 - 2h

Individualized QC 0h 0.25h 1h

Treatment (per session) 10 - 15 min 20 - 25 min 15 min

Page 42: Gregoire H&N

State of the art

• Predictive pattern of lymph node involvement in HNSCC

• Selective neck treatment (irradiation or dissection) for selected N stage

Conformal radiotherapy and IMRTConformal radiotherapy and IMRTin Head and Neck Tumorsin Head and Neck Tumors

Definition of the extend of the CTV in the neck